| FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis M Suker, BR Beumer, E Sadot, L Marthey, JE Faris, EA Mellon, ... The Lancet Oncology 17 (6), 801-810, 2016 | 944 | 2016 |
| A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study JG Scott, A Berglund, MJ Schell, I Mihaylov, WJ Fulp, B Yue, E Welsh, ... The lancet oncology 18 (2), 202-211, 2017 | 461 | 2017 |
| Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated MD Chuong, GM Springett, JM Freilich, CK Park, JM Weber, EA Mellon, ... International Journal of Radiation Oncology* Biology* Physics 86 (3), 516-522, 2013 | 401 | 2013 |
| Sodium and T1ρ MRI for molecular and diagnostic imaging of articular cartilage A Borthakur, E Mellon, S Niyogi, W Witschey, JB Kneeland, R Reddy NMR in Biomedicine: An International Journal Devoted to the Development and …, 2006 | 396 | 2006 |
| Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis QP Janssen, S Buettner, M Suker, BR Beumer, P Addeo, P Bachellier, ... JNCI: Journal of the National Cancer Institute 111 (8), 782-794, 2019 | 313 | 2019 |
| Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer S Rudra, N Jiang, SA Rosenberg, JR Olsen, MC Roach, L Wan, ... Cancer medicine 8 (5), 2123-2132, 2019 | 312 | 2019 |
| Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma EA Mellon, SE Hoffe, GM Springett, JM Frakes, TJ Strom, PJ Hodul, ... Acta oncologica 54 (7), 979-985, 2015 | 257 | 2015 |
| Artifacts in T1ρ-weighted imaging: Compensation for B1 and B0 field imperfections WRT Witschey II, A Borthakur, MA Elliott, E Mellon, S Niyogi, DJ Wallman, ... Journal of magnetic resonance 186 (1), 75-85, 2007 | 195 | 2007 |
| Sodium MR imaging detection of mild Alzheimer disease: preliminary study EA Mellon, DT Pilkinton, CM Clark, MA Elliott, WR Witschey, A Borthakur, ... American Journal of Neuroradiology 30 (5), 978-984, 2009 | 137 | 2009 |
| Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant … EA Mellon, WH Jin, JM Frakes, BA Centeno, TJ Strom, GM Springett, ... Acta Oncologica 56 (3), 391-397, 2017 | 85 | 2017 |
| Dosimetric benefits and practical pitfalls of daily online adaptive MRI-guided stereotactic radiation therapy for pancreatic cancer N El-Bared, L Portelance, BO Spieler, D Kwon, KR Padgett, KM Brown, ... Practical radiation oncology 9 (1), e46-e54, 2019 | 78 | 2019 |
| A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy±intensity modulated radiation therapy TJ Strom, RB Wilder, DC Fernandez, EA Mellon, AS Saini, DC Hunt, ... Radiotherapy and Oncology 111 (1), 126-131, 2014 | 66 | 2014 |
| Persistent TrkA activity is necessary to maintain transcription in neuronally differentiated PC12 cells JH Chang, E Mellon, NC Schanen, JL Twiss Journal of Biological Chemistry 278 (44), 42877-42885, 2003 | 63 | 2003 |
| Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with … EA Mellon, TJ Strom, SE Hoffe, JM Frakes, GM Springett, PJ Hodul, ... Journal of gastrointestinal oncology 7 (4), 547, 2016 | 58 | 2016 |
| Daily tracking of glioblastoma resection cavity, cerebral edema, and tumor volume with MRI-guided radiation therapy S Mehta, SR Gajjar, KR Padgett, D Asher, R Stoyanova, JC Ford, ... Cureus 10 (3), 2018 | 55 | 2018 |
| Personalizing radiotherapy prescription dose using genomic markers of radiosensitivity and normal tissue toxicity in NSCLC JG Scott, G Sedor, JA Scarborough, MW Kattan, J Peacock, GD Grass, ... Journal of Thoracic Oncology 16 (3), 428-438, 2021 | 52 | 2021 |
| Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer MD Chuong, JM Frakes, N Figura, SE Hoffe, R Shridhar, EA Mellon, ... Journal of gastrointestinal oncology 7 (2), 221, 2016 | 49 | 2016 |
| Predictive value of 0.35 T magnetic resonance imaging radiomic features in stereotactic ablative body radiotherapy of pancreatic cancer: A pilot study G Simpson, B Spieler, N Dogan, L Portelance, EA Mellon, D Kwon, ... Medical physics 47 (8), 3682-3690, 2020 | 46 | 2020 |
| The Brain Imaging Collaboration Suite (BrICS): a cloud platform for integrating whole-brain spectroscopic MRI into the radiation therapy planning workflow S Gurbani, B Weinberg, L Cooper, E Mellon, E Schreibmann, S Sheriff, ... Tomography 5 (1), 184, 2019 | 43 | 2019 |
| A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancer EA Mellon, K Javedan, TJ Strom, EG Moros, MC Biagioli, DC Fernandez, ... Practical Radiation Oncology 5 (1), 11-15, 2015 | 42 | 2015 |
